BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 12418358)

  • 1. Safety and tolerability: how do newer generation "atypical" antipsychotics compare?
    Tandon R
    Psychiatr Q; 2002; 73(4):297-311. PubMed ID: 12418358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal side effects of antipsychotic treatment: scope of problem and impact on outcome.
    Tandon R; Jibson MD
    Ann Clin Psychiatry; 2002 Jun; 14(2):123-9. PubMed ID: 12238737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of atypical antipsychotics.
    Stanniland C; Taylor D
    Drug Saf; 2000 Mar; 22(3):195-214. PubMed ID: 10738844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of the atypical antipsychotics. Collaborative Working Group on Clinical Trial Evaluations.
    J Clin Psychiatry; 1998; 59 Suppl 12():17-22. PubMed ID: 9766615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of newer antipsychotics on extrapyramidal function.
    Tarsy D; Baldessarini RJ; Tarazi FI
    CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.
    Leucht S; Wahlbeck K; Hamann J; Kissling W
    Lancet; 2003 May; 361(9369):1581-9. PubMed ID: 12747876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects.
    Conley RR; Kelly DL
    Isr J Psychiatry Relat Sci; 2005; 42(1):51-60. PubMed ID: 16134407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.
    Pierre JM
    Drug Saf; 2005; 28(3):191-208. PubMed ID: 15733025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the CATIE trial on treatment: extrapyramidal symptoms.
    Casey DE
    CNS Spectr; 2006 Jul; 11(7 Suppl 7):25-31. PubMed ID: 16816797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse effects of atypical antipsychotics : differential risk and clinical implications.
    Haddad PM; Sharma SG
    CNS Drugs; 2007; 21(11):911-36. PubMed ID: 17927296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotics: mechanism of action.
    Seeman P
    Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPS profiles: the atypical antipsychotics are not all the same.
    Weiden PJ
    J Psychiatr Pract; 2007 Jan; 13(1):13-24. PubMed ID: 17242588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review.
    Gao K; Kemp DE; Ganocy SJ; Gajwani P; Xia G; Calabrese JR
    J Clin Psychopharmacol; 2008 Apr; 28(2):203-9. PubMed ID: 18344731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choosing an atypical antipsychotic.
    Sussman N
    Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S29-33. PubMed ID: 12570069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of atypical antipsychotic drugs versus conventional medication in schizophrenia.
    Luft B; Taylor D
    Expert Opin Pharmacother; 2006 Sep; 7(13):1739-48. PubMed ID: 16925501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotics from theory to practice: integrating clinical and basic data.
    Tandon R; Milner K; Jibson MD
    J Clin Psychiatry; 1999; 60 Suppl 8():21-8. PubMed ID: 10335668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship of pharmacology to side effects.
    Casey DE
    J Clin Psychiatry; 1997; 58 Suppl 10():55-62. PubMed ID: 9265918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
    Glazer WM
    J Clin Psychiatry; 2000; 61 Suppl 3():16-21. PubMed ID: 10724129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.